Nvidia's Plan to Dominate the World of Robotics ...

Robots just had a coming-out party in Las Vegas. From household helpers to rescue bots, they're now essential-not just novelties. Forbes says it's a $24T opportunity. And Nvidia's CEO says one $7 stock is key to building the world's first trillion-dollar robot.

ACRE
Ares Commercial Real Estate Corp
NYSE
5.22
Open 5.22 Prev Close 5.30
High 5.27 Low 5.22
Volume 174 Volume (Avg) 420
52 Week High 6.33 52 Week Low 3.15
Market Cap 287.3M PE Ratio

Shares Stats

Shares Outstanding55,020,000
Shares Float51,740,000
Shares Short1,920,000
Insider Holdings552%
Institution Holdings44.29%

About Ares Commercial Real Estate Corp

Ares Commercial Real Estate Corporation, a specialty finance company, engages in originating and investing in commercial real estate (CRE) loans and related investments in the United States. It provides loan opportunities for the owners, operators, and sponsors of CRE properties. The company's investments includes senior mortgage loans, subordinate debt, preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities. It has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Corporation was incorporated in 2011 and is based in New York, New York.

General

NameAres Commercial Real Estate Corp
TickerACRE
ExchangeNYSE
SectorReal Estate
IndustryREIT - Mortgage
CurrencyUSD
CountryUSA
Fiscal Year EndDecember

Highlights

Analyst Target4.56
Market Cap287,300,000
PEG Ratio2.57

Financials

Curr Year EPS Estimate-0.30
Next Quarter EPS Estimate-0.03
Profit Margin-9.61%
Operating Margin82.63
Return on Assets-0.00
Return on Equity-0.01
Revenue80.1M
Earnings Per Share-0.14
Revenue Per Share1.60
Gross Profit87,777,000
Quarterly Revenue Growth0.77

Valuation

Forward PE7.34
Price/Sales (Trailing 12 Mt.)3.32
Price/Book (Most Recent Quarter)0.56

Dividend

Ares Commercial Real Estate Corp pays out a dividend of $0.60 per share, with a dividend yield of 11.49%.

ACRE's next dividend payment will be made to shareholders on January 15, 2026.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Jan 15, 2026$0.15
Oct 15, 2025$0.15
Jul 15, 2025$0.15
Apr 15, 2025$0.15
Jan 15, 2025$0.25
Oct 15, 2024$0.25
Jul 16, 2024$0.25
Apr 16, 2024$0.25
Jan 17, 2024$0.33
Most Popular

Jim Cramer Notes 'Horrible' Bitcoin Start To December As BTC Falls By $4,000 In Minutes

Bitcoin (CRYPTO: BTC) is down almost 6% in the past 24 hours after a sudden wave of long-position liquidations erased nearly $4,000 from price in a

Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks

Cathie Wood-led Ark Invest made significant trades involving Tesla, Pony AI, TSMC, and Baidu, highlighting their strategic positioning in tech & AI sectors.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Velo3D Stock Soars After Q3 Earnings: Highlights From The Report

Shares of Velo3D, Inc. (NASDAQ:VELO) are rising Tuesday after the metal 3D printing company reported third-quarter earnings results.

Indigenous groups get the spotlight at UN climate talks, but some say visibility isn't power

BELEM, Brazil (AP) — Indigenous people are used to adapting, so when the power failed at their kickoff event at this year's , they rolled with it. Participants from around the world sweated through song, dance and prayers, improvising without microphones and cooling themselves with fans made of paper or leaves.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low

Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.

New Number One Copper Start Alert - Ad

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

Asian shares are mostly lower despite Wall St rally and a potential end to the US shutdown

BANGKOK (AP) — Asian shares were mostly lower on Tuesday as the recent rebound fueled by buying of technology shares lost steam.

Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Scaramucci Says This One US Mistake Helped China Become a Manufacturing Superpower

Anthony Scaramucci recently highlighted what he considers a significant error by the US that enabled China to ascend as a manufacturing superpower.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

How Tyson's Chicken Business Will Offset Beef Weakness

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

The Next 'Ozempic Moment' Could Be in Heart Disease - Ad

Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.

In Trump-dominated media world, editing video takes on new significance — as BBC uproar shows

In the space of a few months, one of the more straightforward journalistic tasks — editing tape for broadcast — has been behind a $16 million legal settlement, a network's change in how it offers interviews on a news show and, now, the resignation of two top leaders at the BBC.

Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions

NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.

Nevada's Mining Renaissance Is Accelerating - And This Early Opportunity Is Well Positioned - Ad

Nevada's Walker Lane belt has produced 50M+ ounces of gold since the 1800s, and it's waking up again. One of the neighborhood's latest successes just secured over $6M in U.S. support and is up more than 300% YTD. Now a new early-stage explorer has moved in next door.

Japan's SoftBank says it has sold its shares in Nvidia for $5.8 billion

TOKYO (AP) — Japanese technology company SoftBank Group Corp. said Tuesday that it has sold all the Nvidia Corp. shares that it owned for $5.83 billion, while it reported higher than expected profit in the first half of this fiscal year.

These are the 37 donors helping pay for Trump's $300 million White House ballroom

WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Weekend Round-Up: Airbus Chaos, BYD's Massive Recall, Tesla's Free FSD Rides, Rivian's Tax Credit Silver Lining And More

From emergency aircraft recalls to massive vehicle recalls in China, to free self-driving rides in Europe, the past week was buzzing in the auto and tech sector.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

These 8 Democrats voted with Republicans on the government shutdown deal. Here's how they explain it

WASHINGTON (AP) — The Democratic senators — eight in total — faced almost instant blowback from members of their own party as to allow the Senate to move forward on that would reopen the government.

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.

Nvidia's Plan to Dominate the World of Robotics ... - Ad

Robots just had a coming-out party in Las Vegas. From household helpers to rescue bots, they're now essential-not just novelties. Forbes says it's a $24T opportunity. And Nvidia's CEO says one $7 stock is key to building the world's first trillion-dollar robot.

Elon Musk Says SpaceX Will Carry '99% Of All Earth Payload' Once Starship Flies Daily

Elon Musk says SpaceX will handle nearly all of Earth's orbital payloads in the coming years as Starship development continues.

Trump Bars South Africa From 2026 G20 Summit In Florida, Freezes Aid Over 'White Genocide'

President Donald Trump directed that South Africa will not be invited to the 2026 G20 Summit in Miami, Florida. He also declared that all U.S. payments and subsidies to the country would be immediately suspended.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Serbian protesters vow to prevent real estate project linked to Trump son-in-law Kushner

BELGRADE, Serbia (AP) — Thousands of protesters in Serbia symbolically formed a human shield Tuesday around a bombed-out military complex, vowing to protect it from redevelopment as a luxury compound by a company linked to U.S. President Donald Trump’s son-in-law .

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'

President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.

Why Is Occidental Petroleum Stock Gaining Tuesday?

Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.

New Number One Copper Start Alert - Ad

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service